Citations (220)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Iftekhar Mahmood. (2018) Misconceptions and issues regarding allometric scaling during the drug development process. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 843-854.
Read now
Read now
Iftekhar Mahmood. (2015) Prediction of drug clearance in children: a review of different methodologies. Expert Opinion on Drug Metabolism & Toxicology 11:4, pages 573-587.
Read now
Read now
Sherri Smith, Jennifer Hoyt, Nigel Whitebread, Joseph Manna, Marisa Peluso, Kerrie Faia, Veronica Campbell, Martin Tremblay, Somarajan Nair, Michael Grogan, Alfredo Castro, Matthew Campbell, Jeanne Ferguson, Brendan Arsenault, Jylle Nevejans, Bennett Carter, John Lee, Joi Dunbar, Karen McGovern, Margaret Read, Julian Adams, Alexander Constan, Gordon Loewen, Jens Sydor, Vito Palombella & John Soglia. (2013) The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway. Xenobiotica 43:10, pages 875-885.
Read now
Read now
Iftekhar Mahmood. (2013) Allometric scaling and prediction of concentration-time profiles of coagulation factors in humans from animals. Xenobiotica 43:9, pages 774-779.
Read now
Read now
Elliot Offman & Andrea N. Edginton. (2013) Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development. Xenobiotica 43:6, pages 561-569.
Read now
Read now
Kotaro Ogawa, Motohiro Kato, Takao Houjo & Masaki Ishigai. (2013) A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. Xenobiotica 43:5, pages 468-478.
Read now
Read now
Iftekhar Mahmood. (2013) Prediction of drug concentration-time profiles of therapeutic proteins in humans from animals. Xenobiotica 43:2, pages 153-160.
Read now
Read now
Iftekhar Mahmood & Kosalaram Goteti. (2012) Prediction of drug concentration-time data in humans from animals: a comparison of three methods. Xenobiotica 42:8, pages 756-765.
Read now
Read now
Hannah M Jones, Maurice Dickins, Kuresh Youdim, James R Gosset, Neil J Attkins, Tanya L Hay, Ian K Gurrell, Y Raj Logan, Peter J Bungay, Barry C Jones & Iain B Gardner. (2012) Application of PBPK modelling in drug discovery and development at Pfizer. Xenobiotica 42:1, pages 94-106.
Read now
Read now
Rong Deng, Suhasini Iyer, Frank-Peter Theil, Deborah L. Mortensen, Paul J. Fielder & Saileta Prabhu. (2011)
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data. mAbs 3:1, pages 61-66.
Read now
Read now
LorenzR. Rhomberg. (2009) Uptake Kinetics, Species Differences, and the Determination of Equivalent Combinations of Air Concentration and Exposure Duration for Assessment of Acute Inhalation Toxicity. Human and Ecological Risk Assessment: An International Journal 15:6, pages 1099-1145.
Read now
Read now
H. Wong, J.Z. Chen, B. Chou, J.S. Halladay, J.R. Kenny, H. La, J.C. Marsters$suffix/text()$suffix/text(), E. Plise, P.J. Rudewicz, K. Robarge, Y. Shin, S. Wong, C. Zhang & S.C. Khojasteh. (2009) Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor. Xenobiotica 39:11, pages 850-861.
Read now
Read now
Stefan S De Buck & Claire E Mackie. (2007) Physiologically based approaches towards the prediction of pharmacokinetics: in vitro–in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 865-878.
Read now
Read now
Marcella Martignoni, Geny M M Groothuis & Ruben de Kanter. (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opinion on Drug Metabolism & Toxicology 2:6, pages 875-894.
Read now
Read now
LorenzR. Rhomberg & ThomasA. Lewandowski. (2006) Methods for Identifying a Default Cross-Species Scaling Factor. Human and Ecological Risk Assessment: An International Journal 12:6, pages 1094-1127.
Read now
Read now
M. R. Shiran, N. J. Proctor, E. M. Howgate, K. Rowland-Yeo, G. T. Tucker & A. Rostami-Hodjegan. (2006) Prediction of metabolic drug clearance in humans: extrapolation allometric scaling. Xenobiotica 36:7, pages 567-580.
Read now
Read now
Keith W Ward. (2005) Recent advances in pharmacokinetic extrapolation from preclinical data to humans. Expert Opinion on Drug Metabolism & Toxicology 1:4, pages 583-594.
Read now
Read now
R. K. Bhamidipati, P. V. Dravid, R. Mullangi & N. R. Srinivas. (2004) Prediction of clinical pharmacokinetic parameters of linezolid using animal data by allometric scaling: applicability for the development of novel oxazolidinones. Xenobiotica 34:6, pages 571-579.
Read now
Read now
Shufeng Zhou, Philip Kestell & James W. Paxton. (2002) PREDICTING PHARMACOKINETICS AND DRUG INTERACTIONS IN PATIENTS FROM IN VITRO AND IN VIVO MODELS: THE EXPERIENCE WITH 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA), AN ANTI-CANCER DRUG ELIMINATED MAINLY BY CONJUGATION. Drug Metabolism Reviews 34:4, pages 751-790.
Read now
Read now
Chang Youn Cho, Beom Soo Shin, Ji Hoon Jung, Dong Hwan Kim, Kang Choon Lee, Soon-Young Han, Hyung Sik Kim, Byung Mu Lee & Sun Dong Yoo. (2002) Pharmacokinetic scaling of bisphenol A by species-invariant time methods. Xenobiotica 32:10, pages 925-934.
Read now
Read now
A. G. Renwick. (2000) The use of safety or uncertainty factors in the setting of acute reference doses. Food Additives & Contaminants 17:7, pages 627-635.
Read now
Read now
P. SANWALD-DUCRAY & J. DOW*. (1997) Prediction of the pharmacokinetic parameters of reduced- dolasetron in man using in vitro-in vivo and interspecies allometric scaling. Xenobiotica 27:2, pages 189-201.
Read now
Read now
ChamE. Dallas, Xiao
Mei Chen, Srinivasa Muralidhara, Peter Varkonyi, RandallL. Tackett & JamesV. Bruckner. (1995) Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics. Journal of Toxicology and Environmental Health 44:3, pages 301-317.
Read now
Read now
L. P. Balant & M. Gex-fabry. (1990) Review Physiological pharmacokinetic modelling. Xenobiotica 20:11, pages 1241-1257.
Read now
Read now
R. M. J. Ings. (1990) Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20:11, pages 1201-1231.
Read now
Read now
A. E. Tufenkji, M. Alvinerie, T. Pineau, C. Boulard & P. Galtier. (1988) Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep. Xenobiotica 18:4, pages 357-364.
Read now
Read now
Harold Boxenbaum, C. Bruce McCullough & Frederick J. Di Carlo. (1985) Mortality Kinetics in Toxicology Studies. Drug Metabolism Reviews 16:3, pages 321-362.
Read now
Read now
Articles from other publishers (193)
Oluwatobi T. Somade. (2022) Camphor Toxicity: A Review of Recent Findings. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 93:4, pages 775-790.
Crossref
Crossref
Ellen Q. Wang, Nitin Kaila, David Plowchalk, Leonid Gibiansky, Carla Yunis & Kevin Sweeney. (2023)
Population PK/PD modeling of low‐density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent
anti‐PCSK9
monoclonal antibody
. CPT: Pharmacometrics & Systems Pharmacology.
Crossref
Crossref
Shunji Imai, Yusuke Suda, Jumpei Mori, Yoshihiro Sasaki, Tetsuhiro Yamada & Kazutomi Kusano. (2023) Prediction of Human Pharmacokinetics of Phosphorodiamidate Morpholino Oligonucleotides in Duchenne Muscular Dystrophy Patients Using Viltolarsen. Drug Metabolism and Disposition 51:10, pages 1428-1435.
Crossref
Crossref
Miki Yokoyama, Eiko Suzuki, Masataka Oitate & Nobuaki Watanabe. (2023) A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins. European Journal of Drug Metabolism and Pharmacokinetics 48:5, pages 541-552.
Crossref
Crossref
Tridib Chaira, Chandru Subramani & Tarani Kanta Barman. (2023) ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics 15:4, pages 1212.
Crossref
Crossref
Doris Loh & Russel J. Reiter. (2023) Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia. International Journal of Molecular Sciences 24:6, pages 5835.
Crossref
Crossref
Louis Lin, Matthew R. Wright, Cornelis E.C.A. Hop & Harvey Wong. (2022) Physiologically Based Pharmacokinetic Models Can Be Used to Predict the Unique Nonlinear Absorption Profiles of Vismodegib. Drug Metabolism and Disposition 50:9, pages 1170-1181.
Crossref
Crossref
Iftekhar Mahmood. (2022) A Simple Method for the Prediction of Human Concentration–Time Profiles and Pharmacokinetics of Antibody–Drug Conjugates (ADC) from Rats or Monkeys. Antibodies 11:2, pages 42.
Crossref
Crossref
Julia Benzel, Gzona Bajraktari-Sylejmani, Philipp Uhl, Abigail Davis, Sreenath Nair, Stefan M. Pfister, Walter E. Haefeli, Johanna Weiss, Jürgen Burhenne, Kristian W. Pajtler & Max Sauter. (2021) Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS Quantification. Pharmaceutics 13:9, pages 1498.
Crossref
Crossref
Iftekhar Mahmood. (2020) Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling. Antibodies 9:3, pages 40.
Crossref
Crossref
Femke de Velde, Brenda C. M. de Winter, Michael N. Neely, Walter M. Yamada, Birgit C. P. Koch, Stephan Harbarth, Elodie von Dach, Teun van Gelder, Angela Huttner & Johan W. Mouton. (2020) Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate. Clinical Pharmacokinetics 59:7, pages 885-898.
Crossref
Crossref
Seungmok ChoiChanghee KimHeebin SonJae-Kwan HwangWonku Kang. (2020)
Estimation of an Appropriate Human Dose of
Boesenbergia pandurata
Extracts Based on Allometric Scaling Data of Panduratin A in Mice, Rats, and Dogs
. Journal of Medicinal Food 23:4, pages 453-458.
Crossref
Crossref
Katja Jansen, Carla Pou Casellas, Lucianne Groenink, Kimberley E. Wever & Rosalinde Masereeuw. (2020) Humans are animals, but are animals human enough? A systematic review and meta-analysis on interspecies differences in renal drug clearance. Drug Discovery Today 25:4, pages 706-717.
Crossref
Crossref
Nienke J. Vet, Brenda C. M. de Winter, Muriel Koninckx, Shelley A. Boeschoten, Annemie L. M. Boehmer, Jacintha T. Verhallen, Frans B. Plötz, Anja A. Vaessen-Verberne, Bart C. H. van der Nagel, Catherijne A. J. Knibbe, Corinne M. P. Buysse, Saskia N. de Wildt, Birgit C. P. Koch & Matthijs de Hoog. (2019) Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus. Clinical Pharmacokinetics 59:2, pages 257-264.
Crossref
Crossref
Robert S. Jones, Justin Q. Ly & Jae H. Chang. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters
555
594
.
Zheng Lu, Rüdiger Kaspera, Yoichi Naritomi & Tianli Wang. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
671
681
.
Oluwatobi T. Somade, Babajide O. Ajayi, Olubisi E. Adeyi, Blessing O. Aina, Blessing O. David & Ibukunoluwa D. Sodiya. (2019) Activation of NF-kB mediates up-regulation of cerebellar and hypothalamic pro-inflammatory chemokines (RANTES and MCP-1) and cytokines (TNF-α, IL-1β, IL-6) in acute edible camphor administration. Scientific African 5, pages e00114.
Crossref
Crossref
Oluwatobi T. Somade, Babajide O. Ajayi, Nurudeen O. Tajudeen, Eniola M. Atunlute, Adewale S. James & Samuel A. Kehinde. (2019) Camphor elicits up-regulation of hepatic and pulmonary pro-inflammatory cytokines and chemokines via activation of NF-kB in rats. Pathophysiology 26:3-4, pages 305-313.
Crossref
Crossref
Ravi Kumar Jairam, Sadanand Rangnathrao Mallurwar, Suresh P. Sulochana, Devaraj V. Chandrasekhar, Umesh Todmal, Ravi Kanth Bhamidipati, Wolfgang Richter, Nuggehally R. Srinivas & Ramesh Mullangi. (2019) Prediction of Human Pharmacokinetics of Fomepizole from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles. AAPS PharmSciTech 20:6.
Crossref
Crossref
Iftekhar Mahmood. (2019) Initiation of Pediatric Clinical Trials for Coagulation Factors: Application of Pharmacokinetics and Allometry to First‐in‐Pediatric Dose Selection. The Journal of Clinical Pharmacology 59:6, pages 829-834.
Crossref
Crossref
Go-Wun Choi, Yong-Bok Lee & Hea-Young Cho. (2019) Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling. Pharmaceutics 11:4, pages 168.
Crossref
Crossref
Oluwatobi T. Somade, Babajide O. Ajayi, Oluwaseyi A. Safiriyu, Oluwasola S. Oyabunmi & Adio J. Akamo. (2019) Renal and testicular up-regulation of pro-inflammatory chemokines (RANTES and CCL2) and cytokines (TNF-α, IL-1β, IL-6) following acute edible camphor administration is through activation of NF-kB in rats. Toxicology Reports 6, pages 759-767.
Crossref
Crossref
Tim Cardilin, Joachim Almquist, Mats Jirstrand & Johan Gabrielsson. (2018) Evaluation and translation of combination therapies in oncology – A quantitative approach. European Journal of Pharmacology 834, pages 327-336.
Crossref
Crossref
Million A. Tegenge, Iftekhar Mahmood, Zhen Jiang & Richard Forshee. (2018) Multistep Unified Models Using Prior Knowledge for the Prediction of Drug Clearance in Neonates and Infants. The Journal of Clinical Pharmacology 58:7, pages 877-884.
Crossref
Crossref
Takuya Ebihara, Mitsuhiro Nishihara, Junzo Takahashi, Fumihiro Jinno & Yoshihiko Tagawa. (2018) Differences in nonclinical pharmacokinetics between species and prediction of human pharmacokinetics of TAK-272 (SCO-272), a novel orally active renin inhibitor. Biopharmaceutics & Drug Disposition 39:3, pages 175-183.
Crossref
Crossref
Zheng Lu, Rüdiger Kaspera, Yoichi Naritomi & Tianli Wang. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
11
.
Iftekhar Mahmood. (2016) Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach. European Journal of Drug Metabolism and Pharmacokinetics 42:4, pages 601-610.
Crossref
Crossref
Dae Hwan Shin, So-Young Lee, Sung Woo Jeong, Chun-Woong Park & Youn Bok Chung. (2017) Interspecies pharmacokinetic scaling of 11-hydroxyaclanomycin X based on animal data. Journal of Biomedical and Translational Research 18:1, pages 24-29.
Crossref
Crossref
Oluwatobi T. Somade, Kafilat D. Adeniji, Abdul-Rahman A. Adesina & Oluremi J. Olurinde. (2017) Oral acute toxicity study as well as tissues oxidative stress and histopathological disorders in edible camphor administered rats. Experimental and Toxicologic Pathology 69:2, pages 99-108.
Crossref
Crossref
Min-Ho ParkSeok-Ho ShinJin-Ju ByeonGwan-Ho LeeByung-Yong YuYoung G. Shin. (2017) Prediction of pharmacokinetics and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach: A case study of caffeine and ciprofloxacin. The Korean Journal of Physiology & Pharmacology 21:1, pages 107.
Crossref
Crossref
T.H. Grasela, V. Lukacova, D.N. Morris, R.D. Clark, K.A. Andrews & M.B. Bolger. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
51
82
.
Iftekhar Mahmood, Anna Cheng, Edward Brauer & Rita Humeniuk. (2015) Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods. European Journal of Drug Metabolism and Pharmacokinetics 41:6, pages 767-775.
Crossref
Crossref
Franco Lombardo, Giuliano Berellini, Laura R. Labonte, Guiqing Liang & Sean Kim. (2016) Systematic Evaluation of Wajima Superposition (Steady-State Concentration to Mean Residence Time) in the Estimation of Human Intravenous Pharmacokinetic Profile. Journal of Pharmaceutical Sciences 105:3, pages 1277-1287.
Crossref
Crossref
Jing Wang, Suhasini Iyer, Paul J. Fielder, John D. Davis & Rong Deng. (2015) Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development. Biopharmaceutics & Drug Disposition 37:2, pages 51-65.
Crossref
Crossref
Iftekhar Mahmood. 2016. Fundamentals of Pediatric Drug Dosing. Fundamentals of Pediatric Drug Dosing
65
81
.
Dae Hwan Shin, Seung Hyeok Park, Sung Woo Jeong, Oh-Seung Kwon, Chun-Woong Park, Kun Han & Youn Bok Chung. (2015) Pharmacokinetic scaling of epirubicin using allometric and species-invariant time methods. Journal of Pharmaceutical Investigation 45:5, pages 441-448.
Crossref
Crossref
Jie Zhao, Yanguang Cao & William J. Jusko. (2015) Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model. Pharmaceutical Research 32:10, pages 3269-3281.
Crossref
Crossref
Tao Zhang, Tycho Heimbach, Wen Lin, Jin Zhang & Handan He. (2015) Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds. Journal of Pharmaceutical Sciences 104:9, pages 2795-2806.
Crossref
Crossref
O. V. Polekhina, N. V. Obraztsov, V. A. Petrunin & T. A. Vysotskaya. (2015) Interspecies Pharmacokinetics. 2. Analysis of the Structure of Interspecies Relationships Between Parameters of Drug Pharmacokinetics. Pharmaceutical Chemistry Journal 48:10, pages 635-639.
Crossref
Crossref
Iftekhar Mahmood, Carl-Michael Staschen & Kosalaram Goteti. (2014) Prediction of Drug Clearance in Children: an Evaluation of the Predictive Performance of Several Models. The AAPS Journal 16:6, pages 1334-1343.
Crossref
Crossref
Sherwin K. B. Sy, Eduardo Asin-Prieto, Hartmut Derendorf & Emil Samara. (2014) Predicting Pediatric Age-Matched Weight and Body Mass Index. The AAPS Journal 16:6, pages 1372-1379.
Crossref
Crossref
O. V. Polekhina, N. V. Obraztsov, V. A. Petrunin & T. A. Vysotskaya. (2014) Interspecies Pharmacokinetics. 1. Allometric Scaling of Pharmacokinetic Parameters (a Review). Pharmaceutical Chemistry Journal 48:7, pages 421-429.
Crossref
Crossref
Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai & Hideyuki Yamada. (2014) A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes. Drug Metabolism and Disposition 42:9, pages 1540-1547.
Crossref
Crossref
Iftekhar Mahmood & Harold Boxenbaum. (2014) Vertical allometry: Fact or fiction?. Regulatory Toxicology and Pharmacology 68:3, pages 468-474.
Crossref
Crossref
Iftekhar Mahmood. (2014) Dosing in Children: A Critical Review of the Pharmacokinetic Allometric Scaling and Modelling Approaches in Paediatric Drug Development and Clinical Settings. Clinical Pharmacokinetics 53:4, pages 327-346.
Crossref
Crossref
Tycho Heimbach, Rakesh Gollen & Handan He. 2014. Predictive ADMET. Predictive ADMET
319
352
.
I. Mahmood. (2013) Designing first‐in‐human dose of coagulation factors: application of pharmacokinetic allometric scaling. Haemophilia 20:1, pages 32-38.
Crossref
Crossref
Brian R. Moyer. 2014. Pharmaco-Imaging in Drug and Biologics Development. Pharmaco-Imaging in Drug and Biologics Development
113
131
.
Harvey Wong, Stephen E. Gould, Nageshwar Budha, Walter C. Darbonne, Edward E. KadelIIIIII, Hank La, Bruno Alicke, Jason S. Halladay, Rebecca Erickson, Chia Portera, Anthony W. Tolcher, Jeffery R. Infante, Michael Mamounas, John A. Flygare, Cornelis E. C. A. Hop & Wayne J. Fairbrother. (2013) Learning and Confirming with Preclinical Studies: Modeling and Simulation in the Discovery of GDC-0917, an Inhibitor of Apoptosis Proteins Antagonist. Drug Metabolism and Disposition 41:12, pages 2104-2113.
Crossref
Crossref
Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri & Toru Maruyama. (2013)
Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen
γ
-Chain Dodecapeptide as a Synthetic Platelet Substitute
. Drug Metabolism and Disposition 41:8, pages 1584-1591.
Crossref
Crossref
Natalie A. Hosea & Hannah M. Jones. (2013)
Predicting Pharmacokinetic Profiles Using
in Silico
Derived Parameters
. Molecular Pharmaceutics 10:4, pages 1207-1215.
Crossref
Crossref
Binfeng Xia, Tycho Heimbach, Handan He & Tsu‐han Lin. (2012) Nilotinib preclinical pharmacokinetics and practical application toward clinical projections of oral absorption and systemic availability. Biopharmaceutics & Drug Disposition 33:9, pages 536-549.
Crossref
Crossref
Se-Young Choi, Young-Sun Kim, Yeong-Ju Seo, Jehoon Yang & Kyu-Sil Choi. (2012) Gas-Filled Phospholipid Nanoparticles Conjugated with Gadolinium Play a Role as a Potential Theragnostics for MR-Guided HIFU Ablation. PLoS ONE 7:3, pages e34333.
Crossref
Crossref
Ravi Iyengar, Shan Zhao, Seung-Wook Chung, Donald E. MagerJames M. Gallo. (2012) Merging Systems Biology with Pharmacodynamics. Science Translational Medicine 4:126.
Crossref
Crossref
Masataka Oitate, Shintaro Nakayama, Takashi Ito, Atsushi Kurihara, Noriko Okudaira & Takashi Izumi. (2012) Prediction of Human Plasma Concentration-time Profiles of Monoclonal Antibodies from Monkey Data by a Species-invariant Time Method. Drug Metabolism and Pharmacokinetics 27:3, pages 354-359.
Crossref
Crossref
Md Tarique Imam, S. P. Venkateshan, Monika Tandon, Nilanjan Saha & K. K. Pillai. (2011) Comparative Evaluation of US Food and Drug Administration and Pharmacologically Guided Approaches to Determine the Maximum Recommended Starting Dose for First-in-Human Clinical Trials in Adult Healthy Men. The Journal of Clinical Pharmacology 51:12, pages 1655-1664.
Crossref
Crossref
Hee Eun Kang & Myung Gull Lee. (2011) Approaches for predicting human pharmacokinetics using interspecies pharmacokinetic scaling. Archives of Pharmacal Research 34:11, pages 1779-1788.
Crossref
Crossref
Iftekhar Mahmood. (2011) Pharmacokinetic Allometric Scaling of Oligonucleotides. Nucleic Acid Therapeutics 21:5, pages 315-321.
Crossref
Crossref
Tarundeep Kakkar, Cynthia Sung, Leonid Gibiansky, Thuy Vu, Adimoolam Narayanan, Shao-Lee Lin, Michael Vincent, Christopher Banfield, Alex Colbert, Sarah Hoofring, Marta Starcevic & Peiming Ma. (2011) Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor. Pharmaceutical Research 28:10, pages 2530-2542.
Crossref
Crossref
Whitney P. Caron, Harvey Clewell, Robert Dedrick, Ramesh K. Ramanathan, Whitney L. Davis, Ning Yu, Margaret Tonda, Jan H. Schellens, Jos H. Beijnen & William C. Zamboni. (2011) Allometric scaling of pegylated liposomal anticancer drugs. Journal of Pharmacokinetics and Pharmacodynamics 38:5, pages 653-669.
Crossref
Crossref
An Van den Bergh, Vikash Sinha, Ron Gilissen, Roel Straetemans, Koen Wuyts, Denise Morrison, Luc Bijnens & Claire Mackie. (2011) Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data. Clinical Pharmacokinetics 50:8, pages 505-517.
Crossref
Crossref
Iftekhar Mahmood. (1998) Interspecies Scaling: Predicting Volumes, Mean Residence Time and Elimination Half-life. Some Suggestions. Journal of Pharmacy and Pharmacology 50:5, pages 493-499.
Crossref
Crossref
Athiwat Hutchaleelaha, Hsiao-Hui Chow & Michael Mayersohn. (1997) Comparative Pharmacokinetics and Interspecies Scaling of Amphotericin B in Several Mammalian Species. Journal of Pharmacy and Pharmacology 49:2, pages 178-183.
Crossref
Crossref
Thierry Lave, Alphonse Saner, Philippe Coassolo, R Brandt, Anne H Schmitt-Hoffmann & Ruby C Chou. (1996) Animal Pharmacokinetics and Interspecies Scaling from Animals to Man of Lamifiban, a New Platelet Aggregation Inhibitor. Journal of Pharmacy and Pharmacology 48:6, pages 573-577.
Crossref
Crossref
Serge G Jezequel. (1994) Fluconazole: Interspecies Scaling and Allometric Relationships of Pharmacokinetic Properties. Journal of Pharmacy and Pharmacology 46:3, pages 196-199.
Crossref
Crossref
R Lapka. (1991) Pharmacokinetics and brain entry of alaptide, a novel nootropic agent, in mice, rats and rabbits. Journal of Pharmacy and Pharmacology 43:12, pages 874-876.
Crossref
Crossref
Milan Lázníček, Alice Lázníčková, Marie Štětovská & Jaroslav Květina. (1990) Interspecies Pharmacokinetic Scaling of Some Iodinated Organic Acids. Journal of Pharmacy and Pharmacology 42:7, pages 496-499.
Crossref
Crossref
Shinji Yamazaki, Judith Skaptason, David Romero, Sylvia Vekich, Hannah M. Jones, Weiwei Tan, Keith D. Wilner & Tatiana Koudriakova. (2011) Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model. Drug Metabolism and Disposition 39:3, pages 383-393.
Crossref
Crossref
Jennifer Q. Dong, David H. Salinger, Christopher J. Endres, John P. Gibbs, Cheng-Pang Hsu, Brian J. Stouch, Eunju Hurh & Megan A. Gibbs. (2011) Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies. Clinical Pharmacokinetics 50:2, pages 131-142.
Crossref
Crossref
X Zhang, H-H Liu, P Weller, M Zheng, W Tao, J Wang, G Liao, M Monshouwer & G Peltz. (2010) In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor. The Pharmacogenomics Journal 11:1, pages 15-24.
Crossref
Crossref
Masataka Oitate, Noriko Masubuchi, Takashi Ito, Yoshiyuki Yabe, Tsuyoshi Karibe, Takanori Aoki, Nobuyuki Murayama, Atsushi Kurihara, Noriko Okudaira & Takashi Izumi. (2011) Prediction of Human Pharmacokinetics of Therapeutic Monoclonal Antibodies from Simple Allometry of Monkey Data. Drug Metabolism and Pharmacokinetics 26:4, pages 423-430.
Crossref
Crossref
Tobias Pähler & Jochen Maas. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
9
13
.
John P. Gibbs. (2010) Prediction of Exposure–Response Relationships to Support First-in-Human Study Design. The AAPS Journal 12:4, pages 750-758.
Crossref
Crossref
Zvi Teitelbaum, Thierry Lave, Jan Freijer & Adam F. Cohen. (2010) Risk Assessment in Extrapolation of Pharmacokinetics from Preclinical Data to Humans. Clinical Pharmacokinetics 49:9, pages 619-632.
Crossref
Crossref
Iftekhar Mahmood. (2010) Interspecies Scaling for the Prediction of Drug Clearance in Children. Clinical Pharmacokinetics 49:7, pages 479-492.
Crossref
Crossref
Iftekhar Mahmood. (2010) Theoretical Versus Empirical Allometry: Facts Behind Theories Application to Pharmacokinetics. Journal of Pharmaceutical Sciences 99:7, pages 2927-2933.
Crossref
Crossref
William L. Hayton & Teh‐Min Hu. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
28
.
Iftekhar Mahmood. (1999) Prediction of Clearance, Volume of Distribution and Half-life by Allometric Scaling and by use of Plasma Concentrations Predicted from Pharmacokinetic Constants: a Comparative Study. Journal of Pharmacy and Pharmacology 51:8, pages 905-910.
Crossref
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state. Journal of Pharmacy and Pharmacology 55:7, pages 939-949.
Crossref
Crossref
Iftekhar Mahmood. (2010) Prediction of drug clearance in children 3 months and younger: an allometric approach. Drug Metabolism and Drug Interactions 25:1-4.
Crossref
Crossref
Hua Yang, Xingrong Liu, Anjaneya Chimalakonda, Zheng Lu, Cuiping Chen, Frank Lee & Wen Chyi Shyu. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
177
239
.
Jie Ling, Honghui Zhou, Qun Jiao & Hugh M. Davis. (2013) Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look. The Journal of Clinical Pharmacology 49:12, pages 1382-1402.
Crossref
Crossref
Hee E. Kang, Hye Y. Jung, Yu K. Cho, So H. Kim, Se I. Sohn, Seung R. Baek & Myung G. Lee. (2009) Pharmacokinetics of Liquiritigenin in Mice, Rats, Rabbits, and Dogs, and Animal Scale-Up. Journal of Pharmaceutical Sciences 98:11, pages 4327-4342.
Crossref
Crossref
Ashley Roberts & Andrew G. Renwick. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
I. MAHMOOD. (2009) Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators. Haemophilia 15:5, pages 1109-1117.
Crossref
Crossref
Franco Lombardo, R. Scott Obach & Nigel J. Waters. 2009. Hit and Lead Profiling. Hit and Lead Profiling
197
220
.
Kazuaki Taguchi, Toru Maruyama, Yasunori Iwao, Hiromi Sakai, Koichi Kobayashi, Hirohisa Horinouchi, Eishun Tsuchida, Toshiya Kai & Masaki Otagiri. (2009) Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model. Journal of Controlled Release 136:3, pages 232-239.
Crossref
Crossref
Hye Young Ji, Beom Soo Shin, Dong Won Jeong, Eun Jeong Park, Eun-Seok Park, Sun Dong Yoo & Hye Suk Lee. (2009) Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics. Archives of Pharmacal Research 32:2, pages 251-257.
Crossref
Crossref
Aberra Fura, Viral Vyas, William Humphreys, Anjaneya Chimalokonda & David Rodrigues. (2008) Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds. Biopharmaceutics & Drug Disposition 29:8, pages 455-468.
Crossref
Crossref
Chandra Prakash & Alfin D. N. Vaz. 2008. Nuclear Receptors in Drug Metabolism. Nuclear Receptors in Drug Metabolism
1
41
.
Chris Logan. 2008. Drug Bioavailability. Drug Bioavailability
161
184
.
Amy E. Poulin Braim, Melinda H. MacDonald, Michael L. Bruss, Scott D. Stanley, Jill K. Giri & Shri N. Giri. (2008) Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses. American Journal of Veterinary Research 69:7, pages 952-960.
Crossref
Crossref
B.J. Anderson & N.H.G. Holford. (2008) Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics. Annual Review of Pharmacology and Toxicology 48:1, pages 303-332.
Crossref
Crossref
Michael L. Bruss, Scott D. Stanley, Solomon B. Margolin & Shri N. Giri. (2008) Pharmacokinetics and metabolism of intravenous pirfenidone in sheep. Biopharmaceutics & Drug Disposition 29:2, pages 119-126.
Crossref
Crossref
Iftekhar Mahmood. (2007) Prediction of Drug Clearance in Children: Impact of Allometric Exponents, Body Weight, and Age. Therapeutic Drug Monitoring 29:3, pages 271-278.
Crossref
Crossref
J.V. Turner & S. Agatonovic-Kustrin. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
699
724
.
Hong Xiang, Jeanelle McSurdy-Freed, Ganesh S. Moorthy, Erin Hugger, Ramesh Bambal, Chao Han, Santiago Ferrer, Domingo Gargallo & Charles B. Davis. (2006) Preclinical Drug Metabolism and Pharmacokinetic Evaluation of GW844520, A Novel Anti-Malarial Mitochondrial Electron Transport Inhibitor. Journal of Pharmaceutical Sciences 95:12, pages 2657-2672.
Crossref
Crossref
V. I. Pogorel’tsev, S. Yu. Garmonov, M. I. Evgen’ev, E. V. Degterev & V. S. Reznik. (2006) Pharmacokinetics of ximedone. Pharmaceutical Chemistry Journal 40:7, pages 349-352.
Crossref
Crossref
Suresh K. Balani, Nelamangala V. Nagaraja, Mark G. Qian, Arnaldo O. Costa, J. Scott Daniels, Hua Yang, Prakash R. Shimoga, Jing-Tao Wu, Liang-Shang Gan, Frank W. Lee & Gerald T. Miwa. (2006) EVALUATION OF MICRODOSING TO ASSESS PHARMACOKINETIC LINEARITY IN RATS USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY. Drug Metabolism and Disposition 34:3, pages 384-388.
Crossref
Crossref
Hannah M Jones, Neil Parrott, Karin Jorga & Thierry Lav??. (2006) A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics. Clinical Pharmacokinetics 45:5, pages 511-542.
Crossref
Crossref
Hyun J. Shim, Yu C. Kim, Joo H. Lee, Jong W. Kwon, Won B. Kim, Yoon G. Kim, So H. Kim & Myung G. Lee. (2005) Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics. Biopharmaceutics & Drug Disposition 26:7, pages 269-277.
Crossref
Crossref
Tetsufumi Koga, Tomomi Abe, Harumi Inoue, Takashi Takenouchi, Akiko Kitayama, Tatsuhiko Yoshida, Nobuhisa Masuda, Chika Sugihara, Masayo Kakuta, Miyuki Nakagawa, Takahiro Shibayama, Yoko Matsushita, Takashi Hirota, Satoshi Ohya, Yukio Utsui, Takashi Fukuoka & Syogo Kuwahara. (2005) In Vitro and In Vivo Antibacterial Activities of CS-023 (RO4908463), a Novel Parenteral Carbapenem. Antimicrobial Agents and Chemotherapy 49:8, pages 3239-3250.
Crossref
Crossref
V. I. Pogorel'tsev, S. Yu. Garmonov, O. V. Polekhina & V. S. Reznik. (2005) Interspecies Pharmacokinetics of Xymedon. Bulletin of Experimental Biology and Medicine 140:1, pages 58-60.
Crossref
Crossref
Koen Jolling, Juan Jose Perez Ruixo, Alex Hemeryck, An Vermeulen & Tony Greway. (2005) Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin. European Journal of Pharmaceutical Sciences 24:5, pages 465-475.
Crossref
Crossref
M. L. Bruss, S. B. Margolin & S. N. Giri. (2004) Pharmacokinetics of orally administered pirfenidone in male and female beagles. Journal of Veterinary Pharmacology and Therapeutics 27:5, pages 361-367.
Crossref
Crossref
Rakesh Nagilla & Keith W. Ward. (2004) A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans. Journal of Pharmaceutical Sciences 93:10, pages 2522-2534.
Crossref
Crossref
Toshihiro Wajima, Yoshitaka Yano, Kazuya Fukumura & Takayoshi Oguma. (2004) Prediction of Human Pharmacokinetic Profile in Animal Scale up Based on Normalizing Time Course Profiles. Journal of Pharmaceutical Sciences 93:7, pages 1890-1900.
Crossref
Crossref
Keith W. Ward & Brian R. Smith. (2004) A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCE. Drug Metabolism and Disposition 32:6, pages 603-611.
Crossref
Crossref
Iftekhar Mahmood. 2004. New Drug Development. New Drug Development
137
163
.
Thierry Lavé, Olivier Luttringer, Patrick Poulin & Neil Parrott. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development
133
175
.
Susan K. Paulson & Timothy J. Maziasz. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development
405
425
.
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of Human Pharmacokinetics from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis: Oral Clearance. Journal of Pharmaceutical Sciences 92:12, pages 2427-2440.
Crossref
Crossref
Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki & Akira Tsuji. (2003) METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS. Drug Metabolism and Disposition 31:11, pages 1409-1418.
Crossref
Crossref
Olivier Luttringer, Frank‐Peter Theil, Patrick Poulin, Anne H. Schmitt‐Hoffmann, Theodor Walter Guentert & Thierry Lavé. (2003) Physiologically Based Pharmacokinetic (PBPK) Modeling of Disposition of Epiroprim in Humans. Journal of Pharmaceutical Sciences 92:10, pages 1990-2007.
Crossref
Crossref
Margit Spatzenegger, Stephanie Born & James Halpert. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes
179
209
.
Iftekhar Mahmood, Martin David Green & J. Edward Fisher. (2003) Selection of the First-Time Dose in Humans: Comparison of Different Approaches Based on Interspecies Scaling of Clearance. The Journal of Clinical Pharmacology 43:7, pages 692-697.
Crossref
Crossref
Beom S. Shin, Dong H. Kim, Chang Y. Cho, Si K. Park, Sun G. Chung, Eui H. Cho, Sun H. Lee, Jeong H. Joo, Ho S. Kwon, Kang C. Lee & Sun D. Yoo. (2003) Pharmacokinetic scaling of SJ‐8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species‐invariant time methods. Biopharmaceutics & Drug Disposition 24:5, pages 191-197.
Crossref
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2002) Prediction of Human Clearance from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis. Journal of Pharmaceutical Sciences 91:12, pages 2489-2499.
Crossref
Crossref
Iftekhar Mahmood & Chandra Sahajwalla. (2002) Interspecies scaling of biliary excreted drugs. Journal of Pharmaceutical Sciences 91:8, pages 1908-1914.
Crossref
Crossref
Brian J. Anderson & George H. Meakin. (2002) Scaling for size: some implications for paediatric anaesthesia dosing. Pediatric Anesthesia 12:3, pages 205-219.
Crossref
Crossref
Tomás Martín‐Jiménez & Jim E. Riviere. (2002) Mixed‐effects modeling of the interspecies pharmacokinetic scaling of oxytetracycline. Journal of Pharmaceutical Sciences 91:2, pages 331-341.
Crossref
Crossref
I. Mahmood. (2002) Prediction of Clearance in Humans from In Vitro Human Liver Microsomes and Allometric Scaling. A Comparative Study of the Two Approaches. Drug Metabolism and Drug Interactions 19:1.
Crossref
Crossref
Iftekhar Mahmood. (2002) Interspecies Scaling: Predicting Oral Clearance in Humans. American Journal of Therapeutics 9:1, pages 35-42.
Crossref
Crossref
T. Lavé, O. Luttringer, J. Zuegge, G. Schneider, P. Coassolo & F.-P. Theil. 2002. Pharmacokinetic Challenges in Drug Discovery. Pharmacokinetic Challenges in Drug Discovery
81
104
.
T. Martín‐Jiménez & J. E. Riviere. (2008) Mixed effects modeling of the disposition of gentamicin across domestic animal species. Journal of Veterinary Pharmacology and Therapeutics 24:5, pages 321-332.
Crossref
Crossref
P. Aviles, A. Pateman, R. San Roman, M. J. Guillén, F. Gómez De Las Heras & D. Gargallo-Viola. (2001) Animal Pharmacokinetics and Interspecies Scaling of Sordarin Derivatives following Intravenous Administration. Antimicrobial Agents and Chemotherapy 45:10, pages 2787-2792.
Crossref
Crossref
P. Aviles, C. Falcoz, M. J. Guillén, R. San Roman, F. Gómez De Las Heras & D. Gargallo-Viola. (2001)
Correlation between In Vitro and In Vivo Activities of GM 237354, a New Sordarin Derivative, against
Candida albicans
in an In Vitro Pharmacokinetic-Pharmacodynamic Model and Influence of Protein Binding
. Antimicrobial Agents and Chemotherapy 45:10, pages 2746-2754.
Crossref
Crossref
Iftekhar Mahmood. (2001) Interspecies Scaling of Inhalational Anesthetic Potency Minimum Alveolar Concentration (MAC): Application of a Correction Factor for the Prediction of MAC in Humans. American Journal of Therapeutics 8:4, pages 237-241.
Crossref
Crossref
Jochen Zuegge, Gisbert Schneider, Philippe Coassolo & Thierry Lav??. (2001) Prediction of Hepatic Metabolic Clearance. Clinical Pharmacokinetics 40:7, pages 553-563.
Crossref
Crossref
I. Mahmood. (2001) Interspecies Scaling: Is a priori Knowledge of Cytochrome P450 Isozymes Involved in Drug Metabolism Helpful in Prediction of Clearance in Humans from Animal Data?. Drug Metabolism and Drug Interactions 18:2.
Crossref
Crossref
Iftekhar Mahmood. (2013) Interspecies Scaling: Role of Protein Binding in the Prediction of Clearance from Animals to Humans. The Journal of Clinical Pharmacology 40:12, pages 1439-1446.
Crossref
Crossref
Iftekhar Mahmood. (2000) Critique of Prospective Allometric Scaling: Does the Emperor Have Clothes?. The Journal of Clinical Pharmacology 40:6, pages 671-674.
Crossref
Crossref
Iftekhar Mahmood. (2013) Prospective Allometric Scaling: Does the Emperor Have Clothes?. The Journal of Clinical Pharmacology 40:4, pages 341-344.
Crossref
Crossref
Tim Morris. (2000) Anaesthesia in the fourth dimension. Is biological scaling relevant to veterinary anaesthesia?. Veterinary Anaesthesia and Analgesia 27:1, pages 2-5.
Crossref
Crossref
Iftekhar Mahmood. (1999) Allometric issues in drug development†. Journal of Pharmaceutical Sciences 88:11, pages 1101-1106.
Crossref
Crossref
Yuan Hua Wen, Jacob Kalff & Robert Henry Peters. (1999) Pharmacokinetic modeling in toxicology: a critical perspective. Environmental Reviews 7:1, pages 1-18.
Crossref
Crossref
L. Iavarone, J. F. Hoke, M. Bottacini, R. Barnaby & G. C. Preston. (2013) First Time in Human for GV196771: Interspecies Scaling Applied on Dose Selection. The Journal of Clinical Pharmacology 39:6, pages 560-566.
Crossref
Crossref
Iftekhar Mahmood & Rae Yuan. (1999) A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods. Biopharmaceutics & Drug Disposition 20:3, pages 137-144.
Crossref
Crossref
Hiroshi Matsumoto, Yasushi Minowa, Yoko Nishitani & Yuko Fukui. (1999) An allometric model for predicting blood ethanol elimination in mammals. Biochemical Pharmacology 57:2, pages 219-223.
Crossref
Crossref
K Kulig. (1998) Lifetime risk from polyurethane covered breast implants.. Environmental Health Perspectives 106:11.
Crossref
Crossref
W Passchier-Vermeer & W Passchier. (1998) Environmental noise exposure.. Environmental Health Perspectives 106:11.
Crossref
Crossref
Hoan-My Do Luu. (1998) Response. Environmental Health Perspectives 106:11.
Crossref
Crossref
Iftekhar Mahmood. (1998) Interspecies scaling of renally secreted drugs. Life Sciences 63:26, pages 2365-2371.
Crossref
Crossref
Iftekhar Mahmood. (1998) Integration of in Vitro Data and Brain Weight in Allometric Scaling to Predict Clearance in Humans: Some Suggestions†. Journal of Pharmaceutical Sciences 87:4, pages 527-529.
Crossref
Crossref
WERNER KRAUSE. (1998) In Vitro and Animal Experiments in Contrast Media Testing. INVESTIGATIVE RADIOLOGY 33:3, pages 182-191.
Crossref
Crossref
T.H. Lave, S. Dupin, C. Schmitt, R.C. Chou, D. Jaeck & Ph. Coassolo. (1997) Integration of in Vitro Data into Allometric Scaling to Predict Hepatic Metabolic Clearance in Man: Application to 10 Extensively Metabolized Drugs. Journal of Pharmaceutical Sciences 86:5, pages 584-590.
Crossref
Crossref
A.G. Rauws, E.J. De Waal & J.W. Van Der Laan. 1997. Advances in Drug Research Volume 30. Advances in Drug Research Volume 30
15
72
.
I. Mahmood. (1996) Interspecies scaling: predicting clearance of anticancer drugs in humans. European Journal of Drug Metabolism and Pharmacokinetics 21:3, pages 275-278.
Crossref
Crossref
K BachmannD PardoeD White. (1996) Scaling basic toxicokinetic parameters from rat to man.. Environmental Health Perspectives 104:4, pages 400-407.
Crossref
Crossref
Iftekhar Mahmood & John Dikran Balian. (1996) Interspecies Scaling: Predicting Pharmacokinetic Parameters of Antiepileptic Drugs in Humans from Animals with Special Emphasis on Clearance. Journal of Pharmaceutical Sciences 85:4, pages 411-414.
Crossref
Crossref
F. Coudore, A. Besson, A. Eschalier, J. Lavarenne & J. Fialip. (1996) Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after one and six half-life repeated administrations to rats. General Pharmacology: The Vascular System 27:2, pages 215-219.
Crossref
Crossref
Samir C. Mehta & D. Robert Lu. (2006) Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans. Biopharmaceutics & Drug Disposition 16:9, pages 735-744.
Crossref
Crossref
James W. Paxton. (2007) Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: THE ALLOMETRIC APPROACH FOR INTERSPECIES SCALING OF PHARMACOKINETICS AND TOXICITY OF ANTI‐CANCER DRUGS. Clinical and Experimental Pharmacology and Physiology 22:11, pages 851-854.
Crossref
Crossref
Lorenz Rhomberg. (1995) Use of quantitative modelling in methylene chloride risk assessment. Toxicology 102:1-2, pages 95-114.
Crossref
Crossref
G. ZIV, C.V. CREVELD, Z. BEN‐ZVI, A. GLICKMAN & R. YAGIL. (2008) Disposition kinetics of tylosin tartrate administered intravenously and intramuscularly to normal and water‐deprived camels. Journal of Veterinary Pharmacology and Therapeutics 18:4, pages 299-305.
Crossref
Crossref
Eiichi Fuse, Tomowo Kobayashi, Makoto Inaba & Yuichi Sugiyama. (1995) Prediction of the maximal tolerated dose (MTD) and therapeutic effect of anticancer drugs in humans: integration of pharmacokinetics with pharmacodynamics and toxicodynamics. Cancer Treatment Reviews 21:2, pages 133-157.
Crossref
Crossref
F. Coudoré, J. Fialip, A. Eschalier & J. Lavarenne. (2009) Mice plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after half‐life repeated administration. Comparison with acute administration. Fundamental & Clinical Pharmacology 8:6, pages 525-531.
Crossref
Crossref
M. Hildebrand. (1994) Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics. Prostaglandins 48:5, pages 297-312.
Crossref
Crossref
Adalbert Gerard Rauws & Kees Groen. (2016) Future Perspectives on Toxicokinetics: A Regulator's View. Drug Information Journal 28:1, pages 295-300.
Crossref
Crossref
D. Bruce Campbell. (2016) Can Allometric Interspecies Scaling be Used to Predict Human Kinetics?. Drug Information Journal 28:1, pages 235-245.
Crossref
Crossref
J. Kantrowitz & A. Yacobi. 1994. Pharmacokinetics of Drugs. Pharmacokinetics of Drugs
383
403
.
Anna Puigdemont, Joaquim Ramis, Raimon Guitart & Margarita Arboix. (1993) Species Scaling of Propafenone Disposition and Concentration–Time Relationships among Eight Mammalian Species. Journal of Pharmaceutical Sciences 82:11, pages 1126-1129.
Crossref
Crossref
STEPHEN A. GREENE, G. JOHN BENSON & SANDEE M. HARTSFIELD. (2008) Thiamylal‐Sparing Effect of Midazolam for Canine Endotracheal Intubation A Clinical Study of 118 Dogs. Veterinary Surgery 22:1, pages 69-72.
Crossref
Crossref
Mauricio Leal, Avraham Yacobi & Vijay K. Batra. 1993. Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
55
67
.
W.A. Ritschel, N.N. Vachharajani, R.D. Johnson & A.S. Hussain. (1992) The allometric approach for interspecies scaling of pharmacokinetic parameters. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology 103:2, pages 249-253.
Crossref
Crossref
A KuriharaH NaganumaM HisaokaH TokiwaY Kawahara. (1992) Prediction of human pharmacokinetics of panipenem-betamipron, a new carbapenem, from animal data. Antimicrobial Agents and Chemotherapy 36:9, pages 1810-1816.
Crossref
Crossref
H. Marty, O. Varoquaux, J. Fialip, P. Cordonnier, E. Duroux, C. Bulach, A. Eschalier, C. Advenier, M. Pays & P. Bastide. (2009) Compared plasma and brain pharmacokinetics of clomipramine and its metabolite demethylclomipramine in two strains of mice (NMRI and CD1). Fundamental & Clinical Pharmacology 6:2, pages 49-57.
Crossref
Crossref
Anna Puigdemont, Raimon Guitart, Fernando de Mora & Margarita Arboix. (1991) Prediction of the Disposition of Propafenone in Humans and Dogs from Pharmacokinetic Parameters in Other Animal Species. Journal of Pharmaceutical Sciences 80:12, pages 1106-1109.
Crossref
Crossref
K ColemanD R GriffinP A Upshon. (1991) Pharmacokinetic studies and renal dehydropeptidase stability of the new beta-lactamase inhibitor BRL 42715 in animals. Antimicrobial Agents and Chemotherapy 35:9, pages 1748-1752.
Crossref
Crossref
Donald J. Jenden. (1991) Difficulties in using animal data to predict pharmacological response in man. Neuroscience & Biobehavioral Reviews 15:1, pages 105-107.
Crossref
Crossref
WILLARD R. CHAPPELL & JOYCE MORDENTI. 1991.
1
116
.
Jack R. Collins & Gilda H. Loew. (1990) Effect of fluorination of camphor on its binding orientation in p450cam. International Journal of Quantum Chemistry 38:S17, pages 161-171.
Crossref
Crossref
J.K. KIRKWOOD & M.A. WIDDOWSON. (1990) Interspecies variation in the plasma halflife of oxytetracycline in relation to bodyweight. Research in Veterinary Science 48:2, pages 180-183.
Crossref
Crossref
Displaying 200 of 220 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list